ICH’s reflection paper and consultation on patient focused drug development
The document discusses how to better include the patients' perspective into drug development. The public consultation on the Reflection paper is open up to 7 March 2021; it may be followed by the issuing of new ICH's guidelines aimed to harmonise at the global level the approach used to capture patients' point of view on the ongoing development activities
